Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

about

Antibiotic resistance: a rundown of a global crisis

P2860

Q57816209-DFB4D2EC-E2FE-420F-8176-CCEFDAD2F546

P2860

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

Item

http://www.wikidata.org/entity/Q47632421

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

@en

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

@nl

type

Item

label

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

@en

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

@nl

prefLabel

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

@en

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

@nl

P1476

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

@en

P2093

Alain Bouckenooghe

http://www.w3.org/2001/XMLSchema#string

Dhaval M Patel

http://www.w3.org/2001/XMLSchema#string

Guy de Bruyn

http://www.w3.org/2001/XMLSchema#string

Hayato Oka

http://www.w3.org/2001/XMLSchema#string

Josemund Menezes

http://www.w3.org/2001/XMLSchema#string

Osamu Matsuoka

http://www.w3.org/2001/XMLSchema#string

Patricia J Pietrobon

http://www.w3.org/2001/XMLSchema#string

Shin Sasaki

http://www.w3.org/2001/XMLSchema#string

Thelma Laot

http://www.w3.org/2001/XMLSchema#string

Toru Sasaki

http://www.w3.org/2001/XMLSchema#string

P2860

Two-sided confidence intervals for the single proportion: comparison of seven methods

Burden of Clostridium difficile infection in the United States.

Clinical spectrum & pathogenesis of Clostridium difficile associated diseases.

Risk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital.

Burden of Clostridium difficile on the healthcare system.

Clostridium difficile infection: a worldwide disease.

Clostridium difficile: development of a novel candidate vaccine.

Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.

A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults.

Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers.

P304

322-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1395538

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29116880

http://www.w3.org/2001/XMLSchema#string

P932

5806652

http://www.w3.org/2001/XMLSchema#string

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

about

P2860

P2860

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932